Search

Displaying results 1871 - 1880 of 10000 in total
  1. Drug

    Chlorfenson

    go.drugbank.com/drugs/DB05377
    Experimental

    Chlorfenson is developed by Moberg Derma for the treatment of onychomycosis (nail fungus) as the primary indication.

    Synonyms: 4-Chlorophenyl 4-chlorobenzenesulfonate
  2. Drug

    ABT-751

    go.drugbank.com/drugs/DB12254
    Investigational

    ABT-751 has been investigated for the treatment of Lung Cancer, Non-Small Cell Lung Cancer, and Non-Small-Cell Lung Cancer.

    Synonyms: N-[2-(4-hydroxyanilino)-3-pyridinyl]-4-methoxybenzenesulfonamide, N-[2-(4-hydroxyanilino)pyridin-3-yl]-4-methoxybenzenesulfonamide
  3. Drug

    N-[3-[4-(3-aminopropyl)piperazin-1-yl]propyl]-3-[(2-thiophen-2-ylacetyl)amino]-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzamide

    go.drugbank.com/drugs/DB03524
    Experimental

    Synonyms: N-[3-[4-(3-aminopropyl)piperazin-1-yl]propyl]-3-[(2-thiophen-2-ylacetyl)amino]-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzamide
  4. Drug

    Methyl beta-L-fucopyranoside

    go.drugbank.com/drugs/DB03194
    Experimental

    Synonyms: Methyl 6-deoxy-beta-L-galactopyranoside, Methyl beta-L-fucopyranoside
  5. Drug

    5-methylbenzimidazole

    go.drugbank.com/drugs/DB03177
    Experimental

    Synonyms: 6-methyl-1H-benzimidazole, 5-methylbenzimidazoleCategories: Heterocyclic Compounds, 2-Ring
  6. Drug

    Eprosartan

    go.drugbank.com/drugs/DB00876
    ApprovedInvestigational

    It performs 2 actions on the renin angiotensin system. By preventing the binding of angiotensin II to AT1, vascular smooth muscle relaxes and vasodilation occurs.

    Synonyms: (E)-3-[2-n-butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid, (E)-α{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acidMixtures: TEVETEN PLUS 600 MG/12.5 MG FİLM KAPLI TABLET, 56 ADET, Teveten Plus 600 mg/12,5 mg Filmtabletten
  7. Drug

    Panobinostat

    go.drugbank.com/drugs/DB06603
    ApprovedInvestigational

    Panobinostat acts as a non-selective histone deacetylase inhibitor (pan-HDAC inhibitor) and it is the most potent DAC inhibiting agent available on the market. … The approval was accelerated based on progression-free survival, therefore confirmatory trials by the sponsor to demonstrate clinical efficacy in multiple myeloma treatment are in progress of being conducted

    Synonyms: (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide, 2-PROPENAMIDE, N-HYDROXY-3-(4-(((2-(2-METHYL-1H-INDOL-3-YL)ETHYL)AMINO)METHYL)PHENYL)-, (2E)-Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
  8. Drug

    5-aminonaphthalene-2-sulfonic acid

    go.drugbank.com/drugs/DB08238
    Experimental

    Synonyms: 1-naphthylamine-6-sulfonic acid, α-naphthylamine-6-sulfonic acid
  9. Drug

    beta-L-fucose

    go.drugbank.com/drugs/DB03283
    Experimental

    Synonyms: 6-deoxy-beta-L-galactopyranose, beta-L-fucose
  10. Drug

    Cerdulatinib

    go.drugbank.com/drugs/DB15499
    Investigational

    Cerdulatinib is under investigation in clinical trial NCT04021082 (CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/refractory Peripheral T-cell Lymphoma (PTCL)).

    Synonyms: 4-(cyclopropylamino)-2-((4-(4-(ethanesulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide, 5-pyrimidinecarboxamide, 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)-1-piperazinyl)phenyl)amino)-Categories: Heterocyclic Compounds, 1-Ring